<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00148954</url>
  </required_header>
  <id_info>
    <org_study_id>CR-CA-032105-T</org_study_id>
    <secondary_id>RIGHT</secondary_id>
    <nct_id>NCT00148954</nct_id>
  </id_info>
  <brief_title>RIGHT: Rhythm ID Going Head-to-Head Trial</brief_title>
  <official_title>Rhythm ID Going Head-to-head Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RIGHT is a randomized, prospective, two-arm study that will assess the differential efficacy
      of VITALITY 2 implantable cardioverter defibrillators (ICDs) using Rhythm ID™ versus selected
      Medtronic ICDs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RIGHT will compare the incidence of Ventricular Tachycardia/Fibrillation (VT/VF) therapies
      delivered for Supraventricular Tachycardia (SVT) episodes using VITALITY 2 devices with
      Rhythm ID™ to that of ICDs employing other rhythm discrimination algorithms. Appropriateness
      of therapies will be assessed after independent adjudication of all VT/VF events leading to
      therapy. Comparisons will be made between device manufacturers across patient populations
      receiving either a dual- or single-chamber device.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2005</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Patients With Inappropriate Ventricular Tachycardia (VT)/Ventricular Fibrillation (VF) Therapy (Shock or Antitachycardia Pacing [ATP]) After the Pre-Discharge Visit</measure>
    <time_frame>From date of pre-discharge until a minimum of 12 months follow-up until study closure</time_frame>
    <description>An inappropriate therapy is defined as a VT/VF therapy, either shock or antitachycardia pacing (ATP), delivered for a supraventricular tachycardia (SVT). All events for which a VT/VF therapy was delivered and a stored electrogram exists were reviewed by an independent adjudication committee to determine the appropriateness of device rhythm classification and subsequent therapy delivery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to First Inappropriate Shock Using VITALITY and Selected Medtronic Implantable Cardioverter Defibrillator (ICDs)</measure>
    <time_frame>Time of event</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive Predictive Value (PPV) of Ventricular Tachycardia/Fibrillation (VT/VF) Discrimination Algorithms Found in VITALITY 2 and Medtronic Implantable Cardioverter Defibrillators (ICDs)</measure>
    <time_frame>Time of event</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Inappropriate Therapy for Which the Discrimination Algorithm Found in VITALITY 2 and Medtronic Implantable Cardioverter Defibrillator (ICDs) Inappropriately Classified the Episode</measure>
    <time_frame>Time of event</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1962</enrollment>
  <condition>Tachycardia</condition>
  <arm_group>
    <arm_group_label>Implantable Cardioverter Defibrillator - Boston Scientific</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>VITALITY 2 ICD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Implantable Cardioverter Defibrillator - Medtronic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Selected Medtronic family ICD</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VITALITY 2 Implantable Cardioverter Defibrillator</intervention_name>
    <description>VITALITY 2 ICD</description>
    <arm_group_label>Implantable Cardioverter Defibrillator - Boston Scientific</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medtronic Implantable Cardioverter Defibrillator</intervention_name>
    <description>Maximo, Marquis, Intrinsic, Virtuoso, or Entrust ICD</description>
    <arm_group_label>Implantable Cardioverter Defibrillator - Medtronic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who meet current indications for an ICD

          -  Patients who sign and date a Patient Informed Consent form prior to the implant visit

          -  Patients who remain in the clinical care of the enrolling physician in approved
             centers

          -  Patients who are able to tolerate ICD programming as specifically prescribed in the
             study protocol

        Exclusion Criteria:

          -  Patients who are in third degree heart block

          -  Patients whose life expectancy is less than 12 months

          -  Patients who have other cardiac surgeries or procedures planned but not yet performed
             during the duration of the study

          -  Patients who are currently enrolled in another investigational study or registry that
             would directly impact the treatment or outcome of the current study

          -  Patients who are younger than 18 years of age

          -  Patients who are mentally incompetent and cannot sign a Patient Informed Consent form
             or comply with the study

          -  Patients who are pregnant or plan to become pregnant during the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Gold, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ron Berger, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Berger RD, Lerew DR, Smith JM, Pulling C, Gold MR. The Rhythm ID Going Head to Head Trial (RIGHT): design of a randomized trial comparing competitive rhythm discrimination algorithms in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2006 Jul;17(7):749-53.</citation>
    <PMID>16836672</PMID>
  </results_reference>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 6, 2005</study_first_submitted>
  <study_first_submitted_qc>September 7, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2005</study_first_posted>
  <results_first_submitted>October 7, 2011</results_first_submitted>
  <results_first_submitted_qc>November 21, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 26, 2011</results_first_posted>
  <last_update_submitted>January 10, 2012</last_update_submitted>
  <last_update_submitted_qc>January 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>VITALITY 2</title>
          <description>VITALITY 2 ICD</description>
        </group>
        <group group_id="P2">
          <title>Medtronic Family</title>
          <description>Selected Medtronic family devices</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="985"/>
                <participants group_id="P2" count="977"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="678"/>
                <participants group_id="P2" count="677"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="307"/>
                <participants group_id="P2" count="300"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>VITALITY 2</title>
          <description>VITALITY 2 ICD</description>
        </group>
        <group group_id="B2">
          <title>Medtronic Family</title>
          <description>Selected Medtronic family devices</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="985"/>
            <count group_id="B2" value="977"/>
            <count group_id="B3" value="1962"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="489"/>
                    <measurement group_id="B2" value="482"/>
                    <measurement group_id="B3" value="971"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="496"/>
                    <measurement group_id="B2" value="495"/>
                    <measurement group_id="B3" value="991"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.3" spread="12.4"/>
                    <measurement group_id="B2" value="64.4" spread="12.0"/>
                    <measurement group_id="B3" value="64.3" spread="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="223"/>
                    <measurement group_id="B2" value="197"/>
                    <measurement group_id="B3" value="420"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="762"/>
                    <measurement group_id="B2" value="780"/>
                    <measurement group_id="B3" value="1542"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="915"/>
                    <measurement group_id="B2" value="909"/>
                    <measurement group_id="B3" value="1824"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Europe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients With Inappropriate Ventricular Tachycardia (VT)/Ventricular Fibrillation (VF) Therapy (Shock or Antitachycardia Pacing [ATP]) After the Pre-Discharge Visit</title>
        <description>An inappropriate therapy is defined as a VT/VF therapy, either shock or antitachycardia pacing (ATP), delivered for a supraventricular tachycardia (SVT). All events for which a VT/VF therapy was delivered and a stored electrogram exists were reviewed by an independent adjudication committee to determine the appropriateness of device rhythm classification and subsequent therapy delivery.</description>
        <time_frame>From date of pre-discharge until a minimum of 12 months follow-up until study closure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VITALITY 2</title>
            <description>VITALITY 2 ICD</description>
          </group>
          <group group_id="O2">
            <title>Medtronic Family</title>
            <description>Selected Medtronic family devices</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Inappropriate Ventricular Tachycardia (VT)/Ventricular Fibrillation (VF) Therapy (Shock or Antitachycardia Pacing [ATP]) After the Pre-Discharge Visit</title>
          <description>An inappropriate therapy is defined as a VT/VF therapy, either shock or antitachycardia pacing (ATP), delivered for a supraventricular tachycardia (SVT). All events for which a VT/VF therapy was delivered and a stored electrogram exists were reviewed by an independent adjudication committee to determine the appropriateness of device rhythm classification and subsequent therapy delivery.</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="985"/>
                <count group_id="O2" value="977"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="246"/>
                    <measurement group_id="O2" value="187"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.34</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.11</ci_lower_limit>
            <ci_upper_limit>1.62</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Inappropriate Shock Using VITALITY and Selected Medtronic Implantable Cardioverter Defibrillator (ICDs)</title>
        <time_frame>Time of event</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Positive Predictive Value (PPV) of Ventricular Tachycardia/Fibrillation (VT/VF) Discrimination Algorithms Found in VITALITY 2 and Medtronic Implantable Cardioverter Defibrillators (ICDs)</title>
        <time_frame>Time of event</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Inappropriate Therapy for Which the Discrimination Algorithm Found in VITALITY 2 and Medtronic Implantable Cardioverter Defibrillator (ICDs) Inappropriately Classified the Episode</title>
        <time_frame>Time of event</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>VITALITY 2</title>
          <description>This study did not collect serious adverse events</description>
        </group>
        <group group_id="E2">
          <title>Medtronic Family</title>
          <description>This study did not collect serious adverse events</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="535" subjects_at_risk="985"/>
                <counts group_id="E2" subjects_affected="508" subjects_at_risk="977"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Pulse generator Related</sub_title>
                <counts group_id="E1" events="33" subjects_affected="33" subjects_at_risk="985"/>
                <counts group_id="E2" events="21" subjects_affected="21" subjects_at_risk="977"/>
              </event>
              <event>
                <sub_title>Right atrial lead related</sub_title>
                <counts group_id="E1" events="25" subjects_affected="18" subjects_at_risk="985"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="977"/>
              </event>
              <event>
                <sub_title>Right ventricular lead related</sub_title>
                <counts group_id="E1" events="57" subjects_affected="48" subjects_at_risk="985"/>
                <counts group_id="E2" events="77" subjects_affected="60" subjects_at_risk="977"/>
              </event>
              <event>
                <sub_title>Procedure related</sub_title>
                <counts group_id="E1" events="32" subjects_affected="30" subjects_at_risk="985"/>
                <counts group_id="E2" events="26" subjects_affected="25" subjects_at_risk="977"/>
              </event>
              <event>
                <sub_title>Cardiovascular related</sub_title>
                <counts group_id="E1" events="769" subjects_affected="410" subjects_at_risk="985"/>
                <counts group_id="E2" events="690" subjects_affected="373" subjects_at_risk="977"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" events="303" subjects_affected="190" subjects_at_risk="985"/>
                <counts group_id="E2" events="239" subjects_affected="174" subjects_at_risk="977"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Greg Voss, Clinical Director</name_or_title>
      <organization>Boston Scientific</organization>
      <phone>651-581-3068</phone>
      <email>gregory.voss@bsci.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

